Grifols SA (GRLSbn.MC) Company Profile | Reuters.com
Edition:
United States

Profile: Grifols SA (GRLSbn.MC)

GRLSbn.MC on Madrid SE C.A.T.S.

14.07EUR
24 Jun 2016
Change (% chg)

€-0.11 (-0.77%)
Prev Close
€14.19
Open
€13.34
Day's High
€14.10
Day's Low
€13.15
Volume
196,905
Avg. Vol
144,752
52-wk High
€16.84
52-wk Low
€12.50

Grifols SA is a Spain-based company engaged in the healthcare sector. The Company is involved in the research, development, manufacturing and marketing of medical solutions for hospitals, which include plasma-derived therapies, as well as diagnosis and pharmaceutical products. Its activities are structured in five segments: Bioscience, which focuses on the research for obtaining new therapies and solutions aimed at patients who suffer from illnesses stemming from plasma deficits; Diagnostic, which comprises the research, development and marketing of diagnostic products for clinical laboratories, Hospital, which offers ready-to-use pharmaceutical preparations and products for clinical nutrition; Technology, which focuses on automation equipment for the hospital sector; and Raw Materials, which includes sales of biological products and services. The Company is a parent of Grupo Grifols.

Company Address

Grifols SA

Avinguda de la Generalitat
152, Parque empresarial Can Sant
SANT CUGAT DEL VALLES   BAR   08174
P: +34935.712199
F: +34935.710267

Company Web Links